Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2732 USD | -3.22% | -2.81% | -88.42% |
May. 09 | GlycoMimetics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 07 | Capital One Downgrades GlycoMimetics to Equalweight, Price Target at $0.50 | MT |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 2.67M | Capitalization | 17.61M |
---|---|---|---|---|---|
Net income 2024 * | -40M | Net income 2025 * | -41M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 6.59 x |
P/E ratio 2024 * |
-0.44
x | P/E ratio 2025 * |
-0.55
x | Employees | 35 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.92% |
Latest transcript on GlycoMimetics, Inc.
1 day | -3.22% | ||
1 week | -2.81% | ||
Current month | -84.82% | ||
1 month | -85.11% | ||
3 months | -90.58% | ||
6 months | -82.03% | ||
Current year | -88.42% |
Managers | Title | Age | Since |
---|---|---|---|
Harout Semerjian
CEO | Chief Executive Officer | 52 | 21-08-05 |
Rachel King
FOU | Founder | 64 | 03-04-03 |
Brian Hahn
DFI | Director of Finance/CFO | 49 | 10-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel Junius
BRD | Director/Board Member | 71 | 16-03-16 |
Patricia Andrews
BRD | Director/Board Member | 66 | 17-06-11 |
Scott Jackson
BRD | Director/Board Member | 59 | 18-11-27 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-23 | 0.2732 | -3.22% | 1,501,651 |
24-05-22 | 0.2823 | +2.51% | 960,080 |
24-05-21 | 0.2754 | -4.67% | 1,200,743 |
24-05-20 | 0.2889 | -3.51% | 1,676,141 |
24-05-17 | 0.2994 | +6.51% | 2,713,268 |
Delayed Quote Nasdaq, May 23, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-88.42% | 18.19M | |
+10.79% | 115B | |
+11.65% | 106B | |
-6.20% | 24.69B | |
-2.33% | 21.97B | |
-6.03% | 19.27B | |
-13.41% | 17.56B | |
-40.50% | 17.32B | |
+6.64% | 14.03B | |
+31.84% | 12.13B |
- Stock Market
- Equities
- GLYC Stock